Trump’s Condition Has Escalated to... See more .dm
Trump Diagnosed with Chronic Venous Insufficiency
The White House announced on July 17, 2025, that President Donald Trump has been diagnosed with chronic venous insufficiency (CVI), a common circulatory condition. Press Secretary Karoline Leavitt confirmed the diagnosis during a briefing in Washington, D.C., following public observations of swelling in the president’s lower legsChronic venous insufficiency occurs when the valves in the leg veins weaken or become damaged, impairing the return of blood to the heart.
This leads to blood pooling in the lower extremities, often causing swelling (edema), a heavy or achy sensation, and in some cases, skin changes or varicose veins. The condition is particularly prevalent in individuals over 70, and Trump was 79 at the time of diagnosis.
Doctors conducted a thorough medical evaluation, including bilateral lower extremity venous Doppler ultrasounds. The tests confirmed CVI but explicitly ruled out more serious concerns, such as deep vein thrombosis (DVT), arterial disease, or any cardiac issues. An echocardiogram showed normal heart structure and function. White House physicians described the condition as “benign and common,” emphasizing that Trump remains in excellent overall health.
The announcement came after recent public appearances where observers noted Trump moving more slowly and visible swelling around his ankles. Images circulating online also showed bruising on his hands, which officials attributed to frequent handshaking combined with his daily use of aspirin for cardiovascular prevention. Leavitt stressed that the evaluation was performed “out of an abundance of caution.”
Officials reassured the public that CVI is manageable and does not threaten the president’s ability to perform his duties. Standard management typically includes compression stockings, leg elevation, regular walking to improve circulation, weight management, and monitoring. Trump is receiving appropriate care, and his active schedule during a demanding period continues uninterrupted.
The diagnosis generated significant online reaction, with supporters trending hashtags such as #TrumpStrong and offering messages of encouragement. While the condition requires ongoing attention, medical experts note it is rarely life-threatening when properly managed.
This health disclosure highlights a broader truth: even national leaders are subject to age-related medical conditions. The White House’s prompt communication aimed to promote transparency and maintain public confidence. As of early 2026, the condition has been described as stable with no reported complications affecting Trump’s overall health or performance.
The announcement serves as a reminder that proactive medical evaluation remains essential, even for those in high-pressure roles. Updates will be provided as needed while President Trump continues to fulfill his responsibilities.
5 MINUTES AGO: DONALD TRUMP GETS MORE BAD NEWS... SEE MORE.ts1
5 MINUTES AGO: DONALD TRUMP GETS MORE BAD NEWS... SEE MORE.
WASHINGTON, D.C. — July 10, 2026 — President Donald J. Trump returned to the center of international attention this week following a series of major foreign policy announcements made on the sidelines of the 2026 NATO Summit in Ankara, Turkey, held July 8–9.
The developments triggered intense media coverage and widespread political debate as the administration unveiled several major strategic initiatives with potentially far-reaching global consequences.
The heightened attention surrounding the president reflected the rapid pace of policy decisions announced during the summit, where the administration outlined what it described as a new phase of its international security strategy.
Among the most consequential announcements was the decision to grant Ukraine a license to domestically manufacture Patriot air defense missile systems.
According to the administration, the move is designed to strengthen Ukraine's ability to defend itself against continued missile attacks while reducing the need for additional direct U.S. federal spending by allowing production under American authorization.
In another significant diplomatic shift, the administration formally notified Congress of its intention to remove Syria from the U.S. State Sponsors of Terrorism list.
The proposal begins the required 45-day congressional notification process and follows the 2024 political transition in Damascus.
Administration officials argue that the change could help facilitate Syria's gradual reintegration into international financial markets while encouraging broader regional stability.
At the same time, tensions in the Middle East escalated sharply after President Trump declared that the interim ceasefire arrangement with Iran was effectively over.
The announcement followed Iranian-backed attacks targeting commercial shipping in the Strait of Hormuz.
In response, the president authorized multiple rounds of U.S. military strikes against Iranian military facilities and port infrastructure, significantly increasing regional security concerns and drawing immediate international attention.
The combination of these three major policy decisions dominated headlines throughout the summit, with lawmakers, foreign policy analysts, and military experts offering sharply divided assessments of their potential long-term consequences for U.S. national security and global stability.
Administration officials have since emphasized that the actions are part of the president's broader “Peace Through Strength” foreign policy doctrine.
They describe the strategy as one focused on deterrence, military readiness, and expanding American influence through strategic partnerships rather than prolonged direct military intervention.
As President Trump returns to Washington following the NATO summit, attention is now shifting from the immediate diplomatic announcements to their broader geopolitical impact.
The administration is also preparing for the upcoming Pennsylvania Defense and Innovation Summit, scheduled for July 14–15, where national security, defense manufacturing, and emerging technologies are expected to dominate the agenda.
While debate continues in Washington and among U.S. allies overseas, the announcements made in Ankara have already emerged as one of the defining foreign policy moments of the administration.
Analysts are now closely watching how these decisions could shape America's strategic posture and its relationships with allies and adversaries in the months ahead.
5 MINUTES AGO: DONALD TRUMP GETS MORE BAD NEWS... SEE MORE.ts
5 MINUTES AGO: DONALD TRUMP GETS MORE BAD NEWS... SEE MORE
WASHINGTON, D.C. — July 10, 2026 — President Donald J. Trump returned to the center of international attention this week following a series of major foreign policy announcements made on the sidelines of the 2026 NATO Summit in Ankara, Turkey, held July 8–9.
The developments generated intense media coverage and widespread political debate as the administration unveiled several major strategic initiatives with potentially far-reaching global consequences.
The renewed scrutiny surrounding the president reflected the rapid pace of policy decisions announced during the summit, where the administration outlined what it described as a new phase of its international security strategy.
Among the most significant announcements was the decision to grant Ukraine a license to domestically manufacture Patriot air defense missile systems.
According to the administration, the move is designed to strengthen Ukraine's ability to defend itself against continued missile attacks while reducing the need for additional direct U.S. federal spending by allowing production to take place locally under American authorization.
In another major diplomatic shift, the administration formally notified Congress of its intention to remove Syria from the U.S. State Sponsor of Terrorism list.
The proposal begins the required 45-day congressional notification period and follows the 2024 political transition in Damascus.
Administration officials argue that the change could help Syria gradually reenter international financial markets while encouraging broader regional stability.
At the same time, tensions in the Middle East escalated sharply after President Trump declared that the interim ceasefire arrangement with Iran was effectively over.
The announcement followed Iranian-backed attacks targeting commercial shipping in the Strait of Hormuz.
In response, the president authorized multiple rounds of U.S. military strikes against Iranian military facilities and port infrastructure, significantly increasing regional security concerns and drawing immediate international attention.
Together, the three major policy decisions dominated headlines throughout the summit, with lawmakers, foreign policy analysts, and military experts offering sharply divided assessments of their possible long-term consequences for U.S. national security and global stability.
Administration officials have since emphasized that the actions are part of President Trump's broader "Peace Through Strength" foreign policy doctrine.
They describe the strategy as one centered on deterrence, military readiness, and expanding American influence through strategic partnerships rather than prolonged direct intervention.
As President Trump returns to Washington following the NATO summit, attention is beginning to shift from the immediate diplomatic announcements to their broader geopolitical impact.
The administration is now preparing for the upcoming Pennsylvania Defense and Innovation Summit, scheduled for July 14–15, where national security, defense manufacturing, and emerging technologies are expected to take center stage.
While debate continues in Washington and among U.S. allies overseas, the announcements made in Ankara have already emerged as one of the defining foreign policy moments of the administration.
Analysts will now be watching closely to see how these decisions shape America's strategic posture and its relationships with allies and adversaries in the months ahead.
